Platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive impairment

被引:47
|
作者
Gattaz, WF
Forlenza, OV
Talib, LL
Barbosa, NR
Bottino, CMC
机构
[1] Univ Sao Paulo, Fac Med, Dept Psychiat, Neurosci Lab, BR-05403010 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Psychiat, Old Age Res Grp PROTER, BR-05403010 Sao Paulo, Brazil
关键词
dementia; Alzheimer's disease; mild cognitive impairment; brain phospholipids; phospholipase A(2); PLA(2); platelets;
D O I
10.1007/s00702-004-0142-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Phospholipase A(2) (PLA(2)) controls the metabolism of phospholipids in cell membranes. In the brain, PLA(2) influences the processing of the amyloid precursor protein (APP) and thus the production of the amyloid-beta peptides (Abeta), which are the major components of the senile plaques in Alzheimer's disease (AD). Reduced PLA(2) activity has been reported in brain and in platelets of AD patients. In the present study we investigated PLA(2) activity in platelets from 21 AD patients as compared to 17 healthy elderly controls and 11 individuals with mild cognitive impairment (MCI). Subjects were cognitively assessed by the Mini-Mental State Examination (MMSE) and the CAMDEX schedule. Platelet PLA(2) activity was determined by radio-enzymatic assay, which mainly detected a calcium-independent form of the enzyme present also in the brain (iPLA(2)). PLA(2) activity was significantly lower in AD than in controls (p < 0.001). Mean PLA(2) activity in MCI individuals was between the values of AD patients and controls, with a subgroup showing PLA as low as the lowest AD patients, but the differences from MCI were not significant from AD and control groups. Lower PLA(2) activity was significantly correlated with a worse cognitive performance both at the MMSE (p = 0.001) and the cognitive sub-scale of the CAMDEX inventory (p = 0.002). Our data replicate previous findings of reduced platelet PLA(2) activity in AD. Both reduced PLA(2) activity and the correlation with impaired cognition were also reported in brain tissue of AD patients, suggesting thus that the present determinations in platelets may be related to a reduction in the brain. In the brain the inhibition of PLA(2) inhibits the physiological secretion of the APP, a mechanism that increases Abeta formation. Further longitudinal studies should investigate whether those MCI individuals with the lowest PLA(2) values in platelets would be at a higher risk to develop AD during a longitudinal follow up.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 50 条
  • [21] Brain acetylcholinesterase activity impairment and early Alzheimer's in mild cognitive disease
    Rinne, JO
    Kaasinen, V
    Järvenpää, T
    Någren, K
    Roivainen, A
    Yu, M
    Oikonen, V
    Kurki, T
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01): : 113 - 115
  • [22] Mild cognitive impairment: Aging to Alzheimer's disease
    Heilbronner, RL
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (05) : 718 - 722
  • [23] FMRI in mild cognitive impairment and Alzheimer's disease
    Rombouts, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S49 - S49
  • [24] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [25] Mild cognitive impairment and preclinical Alzheimer's disease
    Morris, JC
    GERIATRICS-US, 2005, : 9 - 14
  • [26] The fornix in mild cognitive impairment and Alzheimer's disease
    Nowrangi, Milap A.
    Rosenberg, Paul B.
    FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [27] Dysgraphia in Alzheimer's disease with mild cognitive impairment
    Kavrie, S
    Neils-Strunjas, J
    JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2002, 10 (01) : 73 - 85
  • [28] Metalloproteinase's Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer's Disease
    Martin-Aragon, Sagrario
    Bermejo-Bescos, Paloma
    Benedi, Juana
    Felici, Emanuela
    Gil, Pedro
    Ribera, Jose Manuel
    Villar, Angel Ma
    NEUROCHEMICAL RESEARCH, 2009, 34 (02) : 373 - 378
  • [29] Aging, mild cognitive impairment, and Alzheimer's disease
    Petersen, RC
    NEUROLOGIC CLINICS, 2000, 18 (04) : 789 - +
  • [30] Mild cognitive impairment: Aging to Alzheimer's disease
    Price, CC
    McCoy, KJM
    CLINICAL NEUROPSYCHOLOGIST, 2004, 18 (02): : 204 - 207